[HTML][HTML] A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants

RTS, S Clinical Trials Partnership - New England Journal of …, 2012 - Mass Medical Soc
Background The candidate malaria vaccine RTS, S/AS01 reduced episodes of both clinical
and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing …

A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants.

S Agnandji, B Lell, J Fernandes, B Abossolo… - New England journal …, 2012 - ora.ox.ac.uk
BACKGROUND: The candidate malaria vaccine RTS, S/AS01 reduced episodes of both
clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an …

A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants

ST Agnandji, B Lell, JF Fernandes… - … England Journal of …, 2012 - researchers.cdu.edu.au
Background: The candidate malaria vaccine RTS, S/AS01 reduced episodes of both clinical
and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing …

A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants.

ST Agnandji, B Lell, JF Fernandes… - The New England …, 2012 - europepmc.org
Background The candidate malaria vaccine RTS, S/AS01 reduced episodes of both clinical
and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing …

[HTML][HTML] A Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in African Infants

RTS, S Clinical Trials Partnership… - The New England …, 2012 - stacks.cdc.gov
Background The candidate malaria vaccine RTS, S/AS01 reduced episodes of both clinical
and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing …

A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants.

S RTS, ST Agnandji, B Lell… - The New England …, 2012 - researchonline.lshtm.ac.uk
BACKGROUND: The candidate malaria vaccine RTS, S/AS01 reduced episodes of both
clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an …

A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants

S RTS, ST Agnandji, B Lell… - The New England …, 2012 - pubmed.ncbi.nlm.nih.gov
Background The candidate malaria vaccine RTS, S/AS01 reduced episodes of both clinical
and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing …

[HTML][HTML] A Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in African Infants

RTS The, SCT Partnership, ST Agnandji… - The New England …, 2012 - ncbi.nlm.nih.gov
Background The candidate malaria vaccine RTS, S/AS01 reduced episodes of both clinical
and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing …

A Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in African Infants

S Mian-McCarthy, ST Agnandji… - New England …, 2012 - tobias-lib.ub.uni-tuebingen.de
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants A Phase 3 Trial of RTS,S/AS01
Malaria Vaccine in African Infants DSpace Repositorium (Manakin basiert) Einloggen …

A Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in African Infants

S Mian-McCarthy, ST Agnandji, B Lell… - … England Journal of …, 2012 - ub01.uni-tuebingen.de
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants A Phase 3 Trial of RTS,S/AS01
Malaria Vaccine in African Infants DSpace Repositorium (Manakin basiert) Einloggen …